CIK: 0001831942 · Show all filings
Period: Q3 2021 (← Previous) (Next →)
Filing Date: Nov 15, 2021
Total Value ($000): $379,293 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IVERIC BIO INC | 2,750,137 | $44,662 | 11.8% | $10.18 | — | COM | 46583P102 |
| ACRS | ACLARIS THERAPEUTICS INC | 2,190,291 | $39,425 | 10.4% | $12.44 | +28.8% | COM | 00461U105 |
| CYTK | CYTOKINETICS INC | 796,578 | $28,470 | 7.5% | $24.17 | +21.8% | COM NEW | 23282W605 |
| — | DICERNA PHARMACEUTICALS INC | 1,292,251 | $26,052 | 6.9% | $20.16 | — | COM | 253031108 |
| CCCC | C4 THERAPEUTICS INC | 481,094 | $21,495 | 5.7% | $29.00 | +47.7% | COM STK | 12529R107 |
| KURA | KURA ONCOLOGY INC | 999,433 | $18,719 | 4.9% | $26.59 | -29.1% | COM | 50127T109 |
| CELC | CELCUITY INC | 920,464 | $16,568 | 4.4% | $25.49 | -16.8% | COM | 15102K100 |
| COGT | COGENT BIOSCIENCES INC | 1,912,511 | $16,084 | 4.2% | $9.55 | -19.7% | COM | 19240Q201 |
| — | MERUS N V | 718,136 | $15,799 | 4.2% | $22.00 | — | COM | N5749R100 |
| — | CYMABAY THERAPEUTICS INC | 4,169,896 | $15,220 | 4.0% | $4.81 | — | COM | 23257D103 |
| — | SATSUMA PHARMACEUTICALS INC | 3,118,761 | $14,533 | 3.8% | $6.15 | — | COM | 80405P107 |
| — | VISTAGEN THERAPEUTICS INC | 5,123,509 | $14,038 | 3.7% | $2.24 | — | COM NEW | 92840H202 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 248,207 | $13,401 | 3.5% | $18.18 | +158.1% | COM NEW | 15117B202 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 667,674 | $10,983 | 2.9% | $15.80 | -7.2% | COM | 92790C104 |
| TNYA | TENAYA THERAPEUTICS INC | 513,930 | $10,613 | 2.8% | $21.49 | 0.0% | COM | 87990A106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 362,869 | $8,948 | 2.4% | $23.56 | 0.0% | COM | 462260100 |
| XENE | XENON PHARMACEUTICALS INC | 579,432 | $8,854 | 2.3% | $14.47 | +20.1% | COM | 98420N105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 498,079 | $8,826 | 2.3% | $33.71 | +26.5% | COM | 74366E102 |
| — | KRONOS BIO INC | 298,839 | $6,264 | 1.7% | $29.87 | — | COM | 50107A104 |
| RVMD | REVOLUTION MEDICINES INC | 226,228 | $6,224 | 1.6% | $29.11 | 0.0% | COM | 76155X100 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 3,079,756 | $5,913 | 1.6% | $2.51 | -21.7% | COM NEW | 372427401 |
| KALV | KALVISTA PHARMACEUTICALS INC | 312,553 | $5,454 | 1.4% | $24.62 | -17.7% | COM | 483497103 |
| DYN | DYNE THERAPEUTICS INC | 305,125 | $4,955 | 1.3% | $19.35 | -8.4% | COM | 26818M108 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1,972,958 | $4,775 | 1.3% | $3.56 | — | ADS | 589492107 |
| PMVP | PMV PHARMACEUTICALS INC | 125,000 | $3,725 | 1.0% | $39.23 | -18.6% | COM | 69353Y103 |
| IVA | INVENTIVA SA | 262,658 | $3,719 | 1.0% | $14.53 | — | ADS | 46124U107 |
| — | BCLS ACQUISITION CORP | 250,000 | $2,490 | 0.7% | $11.14 | — | COM CL A | G0904B105 |
| — | ASTRIA THERAPEUTICS INC | 239,270 | $2,115 | 0.6% | $8.84 | — | COM | 04635X102 |
| SPRY | SILVERBACK THERAPEUTICS INC | 97,143 | $969 | 0.3% | $33.40 | -26.2% | COM | 82835W108 |